Amneal Pharmaceuticals, Inc. provided earnings guidance for the full year 2024. For the year, the company expects net revenue to be $2.55 billion - $2.65 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.87 USD | -0.51% | +8.30% | -3.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.29% | 1.81B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Amneal Pharmaceuticals, Inc. Provides Earnings Guidance for the Full Year 2024